Non-alcoholic steatohepatitis (NASH) is a widespread disease affecting up to ~12% of the US population – characterized by lipid accumulation in hepatocytes, infiltration of immune cells and fibrosis of the liver. Replicating liver fibrosis is a key element in any in vitro NASH model, however, it is normally poorly assessed, unquantifiable and has a limited dynamic range.
Senior Scientist
CN Bio
Principal Scientist, Functional Genomics, Discovery Sciences
AstraZeneca
Watch this webinar to learn:
An advanced three-dimensional (3D) microfluidic NASH model has been developed using primary human cells to replicate the human biomarkers of the disease. In this webinar, we will demonstrate how the model can be fine-tuned using exogenous stimuli to enhance key features such as fibrosis or inflammation. We will furthermore discuss the development of an automated workflow to acquire and analyze confocal fluorescent images of these 3D microtissues in order support characterization of fibrosis.
Hear from industry leaders in a series of webinars focused on Organ-on-a-chip technology
Using Microfluidics To Mimic Blood Flow in Single- and Multi-Organ-on-a-Chip . . .
Watch webinarEstablishing strategies to evaluate microphysiological systems for drug . . .
Watch webinarVisit cn-bio.com for more information & news
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN
+44 (0) 1223 737941 | enquiries@cn-bio.com Privacy Policy | Terms | Sitemap
© 2022 CN Bio Innovations
Registered No. 06517359. VAT No. 978184563
For all the latst news visit our news section here
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN
+44 (0) 1223 737941 | enquiries@cn-bio.com Privacy Policy | Terms | Sitemap
© 2022 CN Bio Innovations
Registered No. 06517359. VAT No. 978184563